Irma Dominguez Vigil, MSc, PhD

Irma Dominguez-Vigil earned her undergraduate degree in Pharmaceutical Biology and Chemistry at the School of Chemistry, from the Universidad Autonoma de Nuevo Leon (UANL) in Mexico (2013). She then obtained her Master’s degree in Pharmacy under the supervision of Dr. Benito Mata-Cardenas and Dr. Maria Camacho-Corona at the School of Chemistry, UANL (2015). Later, she earned a PhD degree in Molecular Biology and Genetic Engineering at the School of Medicine, UANL (2020), under the mentorship of Dr. Hugo A. Barrera-Saldana, where she explored genetic biomarkers using noninvasive techniques, such as liquid biopsies, as diagnostic tools for the early detection of gynecological cancers. During her doctoral studies, she obtained an International Academic Exchange Award (CONACyT) to Collaborate at Nuvance Health in Danbury, CT (2018-2020), where she worked with Patient Derived Cell Lines isolated from endometrial, ovarian, and sarcoma tumors as preclinical models for drug sensitivity. Presently, Dr. Dominguez-Vigil has been working on the effects of the small molecule CFI-400945 as an enhancer of radiation therapy in Non-small cell lung cancer (NSCLC) and exploring the interaction of STING with the response to DNA damaging therapy in Head and neck squamous cell carcinoma (HNSCC.